期刊文献+

厄贝沙坦对肾性高血压大鼠血管腺苷三磷酸酶活性和血管紧张素Ⅱ的影响 被引量:6

Effects of Irbesartan on ATPase Activity and Angiotensin Ⅱ in Blood Vessel from Renal Hypertensive Rats
原文传递
导出
摘要 目的探讨厄贝沙坦对肾性高血压大鼠(RHR)血管Na+-K+-腺苷三磷酸酶(ATPase)、Ca2+-ATPase和血管紧张素Ⅱ(AngⅡ)及血管重塑的影响。方法采用两肾一夹制造肾血管性高血压大鼠模型,18只造模成功的大鼠随机分为RHR组、厄贝沙坦组[50 mg/(kg.d)]、停药组[厄贝沙坦50 mg/(kg.d)灌胃7周后停药1周],每组6只。另设一假手术组(n=6)。测量各组大鼠用药前后血压;8周后,测量大鼠胸主动脉及肠系膜动脉血管壁厚度;采用酶学比色法检测Na+-K+-ATPase、Ca2+-ATPase活性;采用放射免疫技术检测血浆、肠系膜动脉及胸主动脉局部AngⅡ水平。结果与假手术组比较,RHR血压显著升高,血管壁厚度明显增厚,血浆及血管组织AngⅡ明显升高,血管Na+-K+-ATPase、Ca2+-ATPase活性降低;与RHR组比较,厄贝沙坦组大鼠血压明显降低,肠系膜动脉血管壁厚度明显减轻,胸主动脉、肠系膜动脉AngⅡ水平及Ca2+-ATPase活性均升高,Na+-K+-ATPase活性无明显变化;与厄贝沙坦组比较,停药组血压明显升高,胸主动脉及肠系膜动脉Ca2+-ATPase活性明显降低,Na+-K+-ATPase活性无变化。RHR血管Ca2+-ATPase活性与局部AngⅡ呈负相关。结论RHR血管重塑与血管组织ATPase活性降低、AngⅡ升高有关,厄贝沙坦逆转血管重塑的作用可能部分与Ca2+-ATPase活性增加有关。 Objective To explore the effects of Irbesartan on activities of Na^+-K^+-ATPase,Ca^2+-ATPase,Angiotensin Ⅱ(Ang Ⅱ)and vascular remodeling in renal hypertensive rats(RHR).Methods Renovascular hypertension was induced by two kidney-one clip method.Eighteen RHR were randomly divided into 3 groups: RHR model group(n=6),Irbesartan treated group [50 mg/(kg·d),n=6],withdrawal group(n=6).Six rats were included in sham operation group.Blood pressure(BP) was measured before and after using irbesartan.Thicknesses of vascular wall(TVW) of thoracic aorta and mesenteric artery were measured after 8 weeks.ATPase activities were determined by enzymatic colorimetric method.Ang Ⅱ level was determined by radioimmunoassay.ResultsCompared to the sham operation group,BP,TVW,Ang Ⅱ of plasma and blood vessel were increased in RHR.The activities of Na^+-K^+-ATPase,Ca^2+-ATPase were decreased in RHR.BP,TVW of mesenteric artery were significantly decreased by irbesartan treatment.An increased Ang Ⅱ level and activity of Ca^2+-ATPase in thoracic aorta and mesenteric artery was also found.No change the activity of Na^+-K^+-ATPase was found after irbesartan treatment.One week after discontinuation of treatment,BP was significantly elevated,the activity of Ca^2+-ATPase of thoracic aorta was decreased(both P0.01),There was a significant negative correlation between Ang Ⅱ and the activity of Ca^2+-ATPase in RHR.Conclusion The vascular remodeling of RHR may be associated with decreased vascular ATPases activities.Irbesartan can reverse vascular remodeling partially by increasing Ca^2+-ATPase activity.
出处 《中华高血压杂志》 CAS CSCD 北大核心 2010年第4期370-374,共5页 Chinese Journal of Hypertension
基金 贵州省优秀青年科技人才基金项目 贵州省科学技术基金重点项目[(2003)0316,(2002)3013]
关键词 腺苷三磷酸酶 血管紧张素Ⅱ 厄贝沙坦 高血压 肾性 大鼠 Adenosinetriphosphatase Angiotensin Ⅱ Irbesartan Hypertension renal Rat
  • 相关文献

参考文献20

  • 1商黔惠,王丕荣,李琮辉,马淑玉,陈剑玲,文雍.多种血管活性物质与细胞膜离子转运与高血压的相互关系[J].中华心血管病杂志,1998,26(5):340-342. 被引量:17
  • 2Ito S, Komatsu K, Yajima Y, et al. Renin-angiotensin system in the brain as a new target of antihypertensive therapy[J]. Hypertens Res,2008,31 (8) :1487-1488.
  • 3Dostanic-Larson l,I.orenz JN, Van Huysse JW, et al. Physiological rote of the alphal- and alpha2-isoforms of the Na^+-K^+-AT-Pase and biological significance of their cardiac glycoside binding site[J]. Am J Physiol Regul Integr Comp Physiol,2006,290 (3): R524-R528.
  • 4Takeuchi K. Molecular mechanism in biological transport in the kidney: Calcium transporters ( Na^+/Ca^2+ exchanger, calcium binding proteins, Ca channels, Ca-ATPase) (Na^+/Ca^2+ exchanger, calcium binding proteins, Ca channels, Ca-ATPase)[J]. Nippon Rinsho,2006,64(suppl 2):150-152.
  • 5White CN, Figtree GA, Liu CC, et al. Angiotensin Ⅱ inhibits the Na^+-K^+ pump via PKC-dependent activation of NADPH oxidase[J]. Am J Physiol Cell Physiol,2009,296(4):C693-700.
  • 6Assuncao-Miranda I, Guilherme AL, Reis-Silva C, et al. Protein kinase C-mediated inhibition of renal Ca^2+ ATPase by physiological concentrations of angiotensin Ⅱ is reversed by AT1- and AT2- receptor antagonists [J]. Regul Pept,2005, 127(1/2/3) : 151-157.
  • 7Jenkins TA. Effect of angiotensin-related antihypertensives on brain neurotransrnitter levels in rats[J]. Neurosci Lett, 2008,444 (2) :186-189.
  • 8Strazzullo P, Galletti F. Impact of the renin-angiotensin system on lipid and carbohydrate metabolism[J]. Curr Opin Nephrol Hypertens,2004, 13(3) : 325-332.
  • 9袁萍,商黔惠,吴芹,秦瑶,吴泽兵,姜黔峰.厄贝沙坦对肾性高血压大鼠左心室肥厚心肌腺苷三磷酸酶和钙调神经磷酸酶的影响[J].中华高血压杂志,2009,17(3):238-242. 被引量:8
  • 10刘利群,毛定安,薄涛,白海涛,莫双红,熊洁.川芎嗪对发育期大鼠惊厥性脑损伤海马ATP酶与脑含水量变化的影响[J].中国急救医学,2006,26(7):518-520. 被引量:4

二级参考文献39

共引文献59

同被引文献52

  • 1刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2611
  • 2谭元生,宋雪云,谭胜真,唐莹,范愈记,张稳.复方七芍降压片治疗高血压病的临床研究[J].中成药,2005,27(7):795-798. 被引量:9
  • 3刘利群,毛定安,薄涛,白海涛,莫双红,熊洁.川芎嗪对发育期大鼠惊厥性脑损伤海马ATP酶与脑含水量变化的影响[J].中国急救医学,2006,26(7):518-520. 被引量:4
  • 4王成,娄探奇,唐骅,彭晖,刘迅,游宇平,陈珠江,余学清.双重阻断肾素-血管紧张素系统对慢性肾脏疾病血压、蛋白尿和肾功能的影响[J].中华肾脏病杂志,2006,22(7):398-401. 被引量:35
  • 5Lara LS,Vives D,Correa JS,et al.PKA-mediated effect of MAS receptor in counteracting angiotensin Ⅱ-stimulated renal Na+-ATPase.Arch Biochem Biophys,2010,496:117-122.
  • 6Ito S,Komatsu K,Yajima Y,et al.Renin-angiotensin system in the brain as a new target of antihypertensive therapy.Hypertens Res,2008,31:1487-1488.
  • 7Dostanic-Larson I,Lorenz JN,Van Huysse JW,et al.Physiological role of the alphal-and alpha2-isoforms of the Na+K+-ATPase and biological significance of their cardiac glycoside binding site.Am J Physiol Regul Integr Comp Physiol,2006,290:R524-R528.
  • 8Vlkovicova J,Javorkova V,Mezesova L,et al.Dual effect of polyphenolic compounds on cardiac Na+/K+-ATPase during development and persistence of hypertension in rats.Can J Physiol Pharmacol 02009,87:1046-1054.
  • 9Choi MR,Medici C,Gironacci MM,et al.Angiotensin Ⅱ regulation of renal dopamine uptake and Na(+),K(+)-ATPase activity.Nephron Physiol,2009,111:53-58.
  • 10Jenkins TA.Effect of angiotensin-related antihypertensives on brain neurotransmitter levels in rats.Neurosci Lett,2008,24:186-189.

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部